EA202092790A1 - HUMAN-ORIENTED ANTIBODY TO DIPEPTIDE REPEAT (DPR) - Google Patents

HUMAN-ORIENTED ANTIBODY TO DIPEPTIDE REPEAT (DPR)

Info

Publication number
EA202092790A1
EA202092790A1 EA202092790A EA202092790A EA202092790A1 EA 202092790 A1 EA202092790 A1 EA 202092790A1 EA 202092790 A EA202092790 A EA 202092790A EA 202092790 A EA202092790 A EA 202092790A EA 202092790 A1 EA202092790 A1 EA 202092790A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dpr
human
antibody
c9orf72
dipeptide repeat
Prior art date
Application number
EA202092790A
Other languages
Russian (ru)
Inventor
Фабио Монтрасио
Ян Гримм
Original Assignee
Нейриммьюн Холдинг Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нейриммьюн Холдинг Аг filed Critical Нейриммьюн Холдинг Аг
Publication of EA202092790A1 publication Critical patent/EA202092790A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6025—Nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

В изобретении предложены новые антитела человека, специфичные в отношении дипептидных повторов (DPR), а также их синтетические варианты и биотехнологические производные, предпочтительно способные связываться с C9ORF72-DPR, а также относящиеся к ним способы. В область изобретения также включены количественные способы исследований, наборы и твердые подложки, относящиеся к указанным антителам, специфичным в отношении DPR и DPR-белков, таких как C9ORF72-DPR. Антитело согласно изобретению может быть использовано в фармацевтических и диагностических композициях для иммунотерапии и диагностики, нацеленной на DPR-белок.The invention provides new human antibodies specific for dipeptide repeats (DPR), as well as their synthetic variants and biotechnological derivatives, preferably capable of binding to C9ORF72-DPR, as well as related methods. Also included within the scope of the invention are quantitative assay methods, kits and solid supports related to said antibodies specific for DPR and DPR proteins such as C9ORF72-DPR. The antibody of the invention can be used in pharmaceutical and diagnostic compositions for immunotherapy and diagnostics targeting the DPR protein.

EA202092790A 2015-08-07 2015-09-30 HUMAN-ORIENTED ANTIBODY TO DIPEPTIDE REPEAT (DPR) EA202092790A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15180310 2015-08-07

Publications (1)

Publication Number Publication Date
EA202092790A1 true EA202092790A1 (en) 2021-07-30

Family

ID=53783654

Family Applications (2)

Application Number Title Priority Date Filing Date
EA202092790A EA202092790A1 (en) 2015-08-07 2015-09-30 HUMAN-ORIENTED ANTIBODY TO DIPEPTIDE REPEAT (DPR)
EA201790433A EA038285B9 (en) 2015-08-07 2015-09-30 Human-derived anti-dipeptide repeat (dpr) antibody

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201790433A EA038285B9 (en) 2015-08-07 2015-09-30 Human-derived anti-dipeptide repeat (dpr) antibody

Country Status (1)

Country Link
EA (2) EA202092790A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014114303A1 (en) * 2013-01-22 2014-07-31 Deutsches Zentrum Für Neurodegenerative Erkrankungen Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion
WO2014116865A1 (en) * 2013-01-24 2014-07-31 Mayo Foundation For Medical Education And Research Methods and materials for detecting c9orf72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or c9orf72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis

Also Published As

Publication number Publication date
EA038285B1 (en) 2021-08-04
EA038285B9 (en) 2022-03-10
EA201790433A1 (en) 2017-09-29

Similar Documents

Publication Publication Date Title
EA201490825A8 (en) TDP-43-SPECIFICALLY BINDING MOLECULES
BR112017006598A2 (en) human derived antidipeptide repeat antibody (dprs)
EA201591020A1 (en) HUMAN ANTI-TAU ANTIBODIES
CL2018003136A1 (en) Specific binding proteins and uses thereof.
EA201890635A1 (en) PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN IMMUNOTHERAPY OF SMALL CELLS OF LUNG AND OTHER CANCER SPECIES
EA201791666A1 (en) CD3 ANTIBODIES, CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES THAT SPECIFICALLY CONNECT WITH CD3 AND / OR CD123
EA201891074A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN CLL IMMUNOTHERAPY AND OTHER CANCER TYPES
EA201890560A1 (en) NEW PEPTIDES, PEPTIDE COMBINATIONS AND FRAMEWORK FOR APPLICATION IN THE IMMUNOTHERAPEUTIC METHOD OF TREATING DIFFERENT CANCER TYPES
EA201791853A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE APPLICATION IN THE IMMUNOTHERAPY OF CANCER OF THE REFERRAL GLAND AND OTHER TYPES OF CANCER
EA201792044A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN LUNG CANCER IMMUNOTHERAPY, INCLUDING NON-SMALL CELL LUNG CANCER AND OTHER CANCER SPECIES
EA201891291A1 (en) MULTI-SPECIFIC ANTIBODIES
EA201190041A1 (en) HUMAN AUTOANTIBODIES AGAINST ALPHA-SINUCLEIN
ECSP12012272A (en) PROTEINS THAT JOIN TNF-?
EA201391761A1 (en) ANTI-ALPHA-SINUCLAIN-BINDING MOLECULES
EA201270571A1 (en) HUMAN IL-23 ANTIGEN-BINDING PROTEINS
EA201792671A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE USE OF EDUCATION AND OTHER SPECIES OF CANCER IN IMMUNOTHERAPY
EA201390669A1 (en) METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY DISEASES OF THE NERVOUS SYSTEM
BR112018071686A2 (en) membrane integral protein display in enveloped extracellular poxvirus virions
CO2020014663A2 (en) Human derived anti (poly-ga) dipeptide repeat antibody (dpr)
EA201790438A1 (en) ANTIGEN-BINDING PROTEINS THAT CONNECT WITH CXCR5
EA201892097A1 (en) ANTIBODIES TO TNF-α AND THEIR FUNCTIONAL FRAGMENTS
EA201790165A1 (en) DESCRIBING HUMAN ANTIBODIES TO GENTINGTIN (HTT) AND THEIR APPLICATION
EA201792466A1 (en) ANTIBODIES AGAINST FcRn
EA201790437A1 (en) ANTIGEN-BINDING PROTEINS CONNECTING WITH CXCR3
EA201892090A1 (en) ANTIBODIES TO TNF-α AND THEIR FUNCTIONAL FRAGMENTS